PUBLISHER: The Business Research Company | PRODUCT CODE: 1270481
PUBLISHER: The Business Research Company | PRODUCT CODE: 1270481
“Dental Biomaterials Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on dental biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for dental biomaterials? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The dental biomaterials market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.
Major players in the dental biomaterials market are Straumann Group, Geistlich Biomaterials, Zimmer Biomet, Dentsply Sirona, 3M Company, Koninklijke DSM N.V., Carpenter Technology Corporation, Kuraray Co. Ltd., Medtronic plc., Henry Schein, Mitsui Chemicals, Victrex plc., Ivoclar Vivadent, GC Corporation, and Bego Medical GmbH.
The global dental biomaterials market is expected to grow from $7.43 billion in 2022 to $8.08 billion in 2023 at a compound annual growth rate (CAGR) of 8.7%.The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The dental biomaterials market is expected to reach $10.77 billion in 2027 at a CAGR of 7.5%.
The dental biomaterials market consists of sales of dental cement, membranes, and soft tissue regeneration products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Dental biomaterials refer to the biological and biosynthetic products used to treat tooth decay, damage, and fractures and also for the restoration of bones and soft tissues, and periodontal structures in dentistry.
North America was the largest region in the dental biomaterials market in 2022. The regions covered in the dental biomaterial report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The main types of dental biomaterials are metallic biomaterials, ceramic biomaterials, polymeric biomaterials, metal-ceramic biomaterials, natural biomaterials and composite biomaterials. Metallic biomaterials, which are frequently utilized in joint replacements, dental implants, orthopedic fixations, and stents, are created to offer internal support to biological tissues. The various bone graft material types are allograft, xenograft, and synthetic. The application includes orthodontics, implantology, prosthodontics, and others, which are used in dental hospitals and clinics, dental laboratories, dental academies, research institutes and dental product manufacturers.
The rising prevalence of dental disorders is expected to propel the growth of the dental biomaterials market going forward. Dental disorders are conditions that harm the oral cavity. Dental biomaterials are helpful in providing effective solutions for dental disorders by providing added protection, remineralization, and bioactive prevention of dental issues, as a result, the rising prevalence of dental disorders increases the demand for the dental biomaterials market. For instance, in March 2022, according to the World Health Organization (the United Nations agency working to promote health), nearly 3.5 billion individuals worldwide suffer from oral disorders, with permanent tooth caries being the most prevalent ailment. According to estimates, 520 million children worldwide suffer from primary tooth decay, whereas 2 billion adults have permanent tooth decay. There are 4 incidences of lip and oral cavity cancer for every 100,000 persons worldwide. Therefore, the rising prevalence of dental disorders drives the dental biomaterials market.
Technological advancements are a key trend that is gaining popularity in the dental biomaterials market. Major companies operating in the market are focused on research and development for product innovations to offer additional benefits and assist in better yield. Such product innovations enable companies to gain a competitive edge in the market. For instance, in May 2021, Botiss Biomaterials GmbH, a Germany-based firm that specializes in the biomaterials for oral tissue regeneration, launched the " NOVAMag regeneration system", an innovative technology in dentistry. This system is mechanically strong yet completely resorbable that can be replaced with bone over time that includes NOVAMag fixation screws, and NOVAMag membrane which is designed to be applied during alveolar ridge augmentation surgeries.
In January 2021, Dentsply Sirona, a US-based dental equipment manufacturer and dental consumables producer acquired Datum Dental, Ltd. for an undisclosed amount. Through this acquisition, Dentsply Sirona aims to develop new, safe and transformational solutions that simplify procedures and overcome major deficiencies in existing biomaterial-based regenerative products. Datum Dental, Ltd. is an Israel-based manufacturer of dental regeneration products with clinically superior proprietary technology.
The countries covered in the dental biomaterials market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The dental biomaterials market research report is one of a series of new reports from The Business Research Company that provides dental biomaterials market statistics, including the dental biomaterials industry's global market size, regional shares, competitors with a dental biomaterials market share, detailed dental biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the dental biomaterials industry. This dental biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.